Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Trump signs order aiming to slash US drug prices to match those abroad

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges

The Guardian - US

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'

Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.

Investors Business Daily

10 'Loser' Stocks Cost Investors 60% Of Their Money Over A Decade

The S&P 500 is a wealth generating machine over the long term. But investors are finding out the hard way it's possible to lose big, too.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

This serum is best-selling for a reason—it tackles everything from dryness to pigmentation, and costs less than £40

The ingredients lineup is impressive

Marie Claire

Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits

ADMA stock plummeted Thursday after the biotech company slightly missed the Street's first-quarter expectations.

Investors Business Daily

The Best Health Care Stocks to Buy

The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.

Kiplinger

Boston Scientific Stock Flirts With A Buy Point, Once Again

Boston Scientific stock is wavering around the buy point of a double-bottom base. The company recently raised its 2025 earnings outlook.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

The 'Double Whammy' That Sent Sarepta Stock To An Eight-Year Low

Sarepta stock plummeted Wednesday on a "double whammy" that includes its trimmed 2025 sales outlook and a critical FDA appointment.

Investors Business Daily

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout

Tuesday's Stock Of The Day is testing a buy point after Verona Pharma broke out last week on blowout sales for its COPD treatment.

Investors Business Daily

Travere Therapeutics Rallies To Buy Point As Kidney Drug Sales Rocket 182%; Anticipates FDA Priority Review For FSGS Treatment

Travere Therapeutics stock reported first quarter results on May 1. The company provides drugs to treat rare diseases.

Investors Business Daily

Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug

Neurocrine Biosciences shares catapulted Tuesday on "surprising commercial momentum" for its newest drug, Crenessity.

Investors Business Daily

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Vertex stock skidded Tuesday on a series of first-quarter setbacks that included light sales, slow uptake for two drugs and a paused study.

Investors Business Daily

Mutual Funds Gobble Up Eli Lilly Stock, Ge Vernova And A Wrestling Name

Eli Lilly stock is in a long consolidation pattern and below a critical moving average.

Investors Business Daily

Americans would suffer most if Trump imposes pharma tariffs, sector warns

Industry says levies would hit supply chains, making medicines potentially unaffordable for some US patients

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Snake collector’s immunity quest opens path towards universal antivenom

Blood from man bitten hundreds of times by deadly snakes is used to create most broadly protective antivenom yet

The Guardian - UK

Trump hints at tariff reprieve for pharma companies that bring operations back to US

He suggests drugmakers would get ‘a lot of time’ to repatriate manufacturing before facing levies

Investors Business Daily

Is Biogen At The 'Start Of A Turnaround' On Its Quarterly Beat?

Biogen stock traded sideways Thursday after the company beat first-quarter expectations, including strong sales for two newcomer drugs.

Investors Business Daily

Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline

Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Argenx Stock Extends Rally In A Base As Earnings Loom

Argenx stock is rising Wednesday as the major indexes sell off. The autoimmune disease treatment stock is climbing in an early-stage base.

Medical Daily

Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors

A pharmaceutical company that paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million.

Investors Business Daily

BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations

BridgeBio stock broke out Wednesday after its new heart drug, a rival to Pfizer's blockbuster Vyndaqel, smashed sales expectations.

The Independent UK

You might soon be able to get Wegovy from an online shop — here is where you need to visit

The move comes as Danish drugmaker Novo Nordisk has acted to slash the popular weight loss drug’s price

International Business Times

AstraZeneca Moves Some Production To US Amid Tariff Threat

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.

The Guardian - UK

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal Soriot

Investors Business Daily

CG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer Drug

Shares of CG Oncology catapulted Monday after the biotech unveiled promising results for a J&J-rivaling bladder cancer treatment.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Vertex Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.